INTRODUCING SYSTAGENIX WOUND MANAGEMENT, A NEW GLOBAL FORCE IN ADVANCED WOUND CARE
2 December 2008 SYSTAGENIX WOUND MANAGEMENT, a new portfolio company created by One Equity Partners1 launched today with the intent of establishing a new global force in advanced wound care committed to providing innovative products that help enhance patients’ quality of life. Systagenix Wound Management, formerly the Professional Wound Care Business of Ethicon Inc2., a Johnson & Johnson Company, is focused on achieving further success, whilst building on its internationally renowned advanced and general wound care product portfolios. These include brands such as PROMOGRAN Matrix Wound Dressing, PRISMA Matrix, SILVERCEL Antimicrobial Alginate Dressing and REGRANEX (becaplermin) Gel 0.01%. These brands will be sold, marketed and developed by the same team and will continue to focus on meeting the needs our customers. Therefore, it is business as usual for customers while there is a new emphasis and focus within the organization Systagenix Wound Management’s newly appointed senior management team is headed up by Executive Chairman, Chris Fashek and CEO Steve Atkinson. The new company will be headquartered in the UK, including a manufacturing and R&D facility based in Gargrave, North Yorkshire, UK. Steve Atkinson, CEO of Systagenix Wound Management, comments, “We are totally focused on making Systagenix Wound Management the strongest and most admired wound care company. We have inherited a business with a strong heritage and outstanding pedigree providing an excellent platform for future growth. The wound care market represents substantial opportunity and with our investment plan, customer relationships and scientific and technical capabilities, Systagenix will become the driving force in the industry.” Guidance Notes: 1. Established in 2001, One Equity Partners manages $8 billion of investments and commitments for J.P. Morgan Chase & Co. in direct private equity transactions. Over recent years, One Equity Partners has invested approximately $3.5 billion to acquire over thirty companies in a variety of industries including defense, chemicals, healthcare, technology and manufacturing. One Equity Partners' investment professionals are located across North America, Europe and Asia, with offices in New York, Chicago, Menlo Park, Frankfurt and Hong Kong. Visit https://www.oneequity.com/ for more information. 2. ETHICON, Inc., a Johnson & Johnson company, is a global medical device company that develops and markets surgical products for use in general surgery, wound management and women's health & urology. For more information about ETHICON, please visit www.ethicon.com.
